NCT06427005 2025-01-22Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRCWest China HospitalPhase 2 Unknown66 enrolled
NCT06169202 2023-12-13A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of PatientsChina Medical University, ChinaUnknown50 enrolled